{"pmid":32406283,"title":"A survey of psoriasis patients on biologics during COVID-19: a single centre experience.","text":["A survey of psoriasis patients on biologics during COVID-19: a single centre experience.","J Dermatolog Treat","Burlando, M","Carmisciano, L","Cozzani, E","Parodi, A","32406283"],"journal":"J Dermatolog Treat","authors":["Burlando, M","Carmisciano, L","Cozzani, E","Parodi, A"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32406283","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1080/09546634.2020.1770165","keywords":["covid-19","biologic treatment","psoriasis"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1666802845422190592,"score":9.490897,"similar":[{"pmid":32358864,"title":"Biologic therapy for psoriasis during the COVID-19 outbreak: the choice is to weigh risks and benefits.","text":["Biologic therapy for psoriasis during the COVID-19 outbreak: the choice is to weigh risks and benefits.","Dermatol Ther","Conforti, Claudio","Giuffrida, Roberta","Dianzani, Caterina","Di Meo, Nicola","Zalaudek, Iris","32358864"],"journal":"Dermatol Ther","authors":["Conforti, Claudio","Giuffrida, Roberta","Dianzani, Caterina","Di Meo, Nicola","Zalaudek, Iris"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32358864","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/dth.13490","keywords":["covid-19","sars-cov-2","biologic treatment","biologics","psoriasis","psoriatic arthritis. guidelines"],"topics":["Prevention"],"weight":1,"_version_":1666138495316393986,"score":121.96214},{"pmid":32283234,"pmcid":"PMC7146699","title":"Biologics for psoriasis during COVID-19 outbreak.","text":["Biologics for psoriasis during COVID-19 outbreak.","J Am Acad Dermatol","Di Lernia, Vito","32283234"],"journal":"J Am Acad Dermatol","authors":["Di Lernia, Vito"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32283234","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jaad.2020.04.004","keywords":["covid-19","biologics","coronavirus","immunosuppression","psoriasis","treatment"],"topics":["Treatment"],"weight":1,"_version_":1666138491460780032,"score":106.69343},{"pmid":32314483,"title":"COVID-19 and psoriasis: Should we fear for patients treated with biologics?","text":["COVID-19 and psoriasis: Should we fear for patients treated with biologics?","The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midst of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision.","Dermatol Ther","Amerio, Paolo","Prignano, Francesca","Giuliani, Federica","Gualdi, Giulio","32314483"],"abstract":["The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midst of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision."],"journal":"Dermatol Ther","authors":["Amerio, Paolo","Prignano, Francesca","Giuliani, Federica","Gualdi, Giulio"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314483","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/dth.13434","keywords":["covid-19","sars","biologics","psoriasis","therapy"],"topics":["Treatment"],"weight":1,"_version_":1666138493540106240,"score":102.70167},{"pmid":32338424,"title":"Biologics for psoriasis in COVID-19 era: what do we know?","text":["Biologics for psoriasis in COVID-19 era: what do we know?","Dermatol Ther","Megna, M","Napolitano, M","Patruno, C","Fabbrocini, G","32338424"],"journal":"Dermatol Ther","authors":["Megna, M","Napolitano, M","Patruno, C","Fabbrocini, G"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32338424","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/dth.13467","keywords":["covid-19","biologics","psoriasis"],"topics":["Prevention"],"weight":1,"_version_":1666138494219583489,"score":98.28107},{"pmid":32387660,"title":"COVID-19 and biologics for psoriasis: a high-epidemic area experience - Bergamo, Lombardy, Italy.","text":["COVID-19 and biologics for psoriasis: a high-epidemic area experience - Bergamo, Lombardy, Italy.","J Am Acad Dermatol","Carugno, Andrea","Gambini, Daniele Mario","Raponi, Francesca","Vezzoli, Pamela","Locatelli, Andrea Gustavo C","Di Mercurio, Marco","Test, Elisa Robustelli","Sena, Paolo","32387660"],"journal":"J Am Acad Dermatol","authors":["Carugno, Andrea","Gambini, Daniele Mario","Raponi, Francesca","Vezzoli, Pamela","Locatelli, Andrea Gustavo C","Di Mercurio, Marco","Test, Elisa Robustelli","Sena, Paolo"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32387660","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jaad.2020.04.165","keywords":["2 (sars-cov-2)","biologic therapy","covid-19","coronavirus","dermatology","psoriasis","severe acute respiratory syndrome","skin"],"locations":["Lombardy","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666428892645163009,"score":92.9568}]}